| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | QC4F7FKK7I |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Angiopoietin-2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Macular Edema | 4 | D008269 | FDA |
| Macular Degeneration | 3 | D008268 | ClinicalTrials |
| Macular Degeneration | 3 | D008268 | ClinicalTrials |
| Choroidal Neovascularization | 2 | D020256 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1607793-29-2 |
| ChEMBL | CHEMBL4297750 |
| FDA SRS | QC4F7FKK7I |
CONTENTS